ScholarMate
English简体中文繁體中文
Customer service: 400-1616-289
Sign inSign up
Journal article

Clinical Outcomes and Prognostic Factors of Salvage Stereotactic Body Radiotherapy for Post-Surgical Thoracic Oligo-Recurrence/Metastasis of Non-Small-Cell Lung Cancer

Li, Wen-Cai; Wang, Zhen; Gao, Jie; Zhou, Han; Li, Jing; Zhu, Xi-Xu*南方医科大学; 1
Cancer Management and Research2021DOI: 10.2147/CMAR.S287993
4Cited by15Reads
CiteSave
Share

Abstract

Purpose: The study aimed to assess the efficacy and safety of stereotactic body radiotherapy (SBRT) using CyberKnife (CK) in patients with postoperative thoracic oligo-recurrence/metastasis of non-small-cell lung cancer (NLCLC), and to analyze the prognostic factors affecting overall survival after SBRT. @@@ Patients and Methods: A total of 44 patients with postoperative thoracic oligorecurrence/metastatic of NLCLC treated with SBRT were reviewed. Thoracic oligorecurrence/was defined as 1-3 loco-regional confined to lung lobe, hilar/mediastinal lymph nodes, bronchial stump, or chest wall. Primary endpoints included local control (LC), overall survival (OS), progression-free survival (PFS) and toxicity. Prognostic factors that affected these patients were analyzed by the univariate and multivariate analysis by Kaplan-Meier methods and Cox regression models, respectively. @@@ Results: The median follow-up time after salvage SBRT was 48.5 months. Measuring from the date of salvage SBRT, the median OS of the 44 patients was 52.60 (95% CI: 29.59-75.60) months. 1-,3-and 5-year OS rates were 97.7%, 65.3% and 47.7%, respectively. The 1-,3-year and 5-year LC rates were 97.7%, 85.1% and 80.1%, respectively. At 1, 3 and 5 years, the PFS rates were 77.1%, 28.8% and 5.3%, respectively. Multivariate analysis demonstrated that pre-SBRT neutrophil-to-lymphocyte ratio (NLR) and Charlson comorbidity index (CCI) were independent prognostic factors (p < 0.05). The treatment-related side-effects were well tolerated. No patients developed grade 3 or greater pulmonary toxicity. @@@ Conclusion: SBRT is a promising salvage therapeutic option for postoperative thoracic oligo-recurrence/metastasis of non-small-cell lung cancer with acceptable toxicity. Low preSBRT neutrophil-to-lymphocyte ratio (NLR) and low Charlson comorbidity index (CCI) were associated with a better prognosis and longer survival and might be considered as reliable and independent prognostic factors in these patients treated with SBRT.

Disciplines and keywords

Keywords
oligo-recurrenceNSCLCpost-surgical recurrenceCyberKnife
Related
Loading…

Could not load papers. Please retry.

Retry

Publication info

Publication status
Published
Journal
Cancer Management and Research
Publication date
2021
Volume / issue
Vol. 13
Pages
1887-1896
DOI
10.2147/CMAR.S287993
Journal indexing
NSL
Journal ranking
Q3
Output indexing
SCIE

Authors

  • L

    Li, Wen-Cai (First author)

    1 · southern med univ

  • W

    Wang, Zhen

View all 6 authorsShow fewer authors
  • G

    Gao, Jie

  • Z

    Zhou, Han

  • L

    Li, Jing

  • Z

    Zhu, Xi-Xu (Corresponding)

    1 · southern med univ

Sign in for more features

  • Save this paper in My collections
  • Claim your outputs and generate promotion materials
  • Follow authors for new outputs
  • Join groups and collaborate
Sign up / Sign in

Products

  • ScholarMate
  • InnoCity
  • IRISaaS

Support

  • Help Center
  • Privacy Policy
  • Terms of Service

Contact

Online support: []
Customer service: 400-1616-289
Email: support@scholarmate.com

Follow or download ScholarMate

WeChat QR code
WeChat official account
App download QR code
Download the app
OutputsResearchersResearch institutionsResearch newsIRISaaS

©2026 深圳市科研之友网络服务有限公司

Public security registration badge粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417